Glucagon-like peptide 1 receptor agonists (GLP-1RAs) have rapidly emerged as game-changers in treating diabetes, heart ...

As demand for weight-loss injections sold under brand names such as Ozempic and Wegovy continues to soar, a study has ...

Get real-time updates on health from celebrity fitness secrets and weight loss breakthroughs to nutrition advice, get your ...

One of the hottest growth areas in the healthcare landscape these days is the obesity drug market because of a class of drugs ...

Eating breakfast regularly has been shown to help reduce the risk of developing type 2 diabetes, cardiovascular disease and obesity, according to UC Davis Health. There is also evidence that eating a ...

The skyrocketing popularity of weight-loss drugs is fast becoming a state budgetary concern. Policymakers must choose between ...

Glucagon-like peptide 1 receptor agonists (GLP1RA)—medications for type 2 diabetes and obesity that have recently been making headlines due to a rise in popularity as weight loss agents—have been ...

A woman who lost 64 pounds on a compounded form of the weight loss drug semaglutide, marketed as Wegovy and Ozempic, started ...

“They have no nutritional value ... Small amounts of trans fats can increase the risk for cardiovascular disease significantly,” says Dr. Lopez-Jimenez. “They usually come in the form of partially ...

The “Plant, Pick & Plate Program” teaches children in southeast Fort Wayne hands-on gardening and cooking skills through ...

The benefits of taking GLP-1 agonists seem to outweigh the risks, at least when taken for approved uses, according to an ...

An international team of doctors proposed a new way to define obesity that's not based solely on BMI. Here's what they ...